Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Effective treatment improved skin and overall symptoms in a lupus patient.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The meeting highlighted the complexity and variability of skin conditions and differing opinions on their diagnoses and treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.